Vor Biopharma

$30.10
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.40 (-4.44%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Vor Biopharma and other stocks, options, and ETFs commission-free!

About VOR

Vor Biopharma Inc. Common Stock, also called Vor Biopharma, is a clinical-stage cell therapy company that combines a novel patient engineering approach with therapies to provide a single company solution for patients suffering from hematological malignancies.

CEO
Bob Ang
Employees
88
Headquarters
Cambridge, Massachusetts
Founded
2015
Market Cap
1.03B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
129.55K
High Today
$31.91
Low Today
$28.33
Open Price
$31.91
Volume
150.55K
52 Week High
$63.62
52 Week Low
$25.32

VOR Earnings

Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 7, After Hours

You May Also Like

VFC
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure